1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Systemic Aspergillosis and Systemic Candidasis Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Systemic Aspergillosis and Systemic Candidasis Market Regional Analysis
6.2 Europe Systemic Aspergillosis and Systemic Candidasis Market Revenue 2017-2027 (US$ Million)
6.3 Europe Systemic Aspergillosis and Systemic Candidasis Market Forecast Analysis
7. Europe Systemic Aspergillosis and Systemic Candidasis Market Analysis – by Type
7.1 Voriconazole
- 7.1.1 Overview
- 7.1.2 Voriconazole: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Liposomal
- 7.2.1 Overview
- 7.2.2 Liposomal: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Amphotericin B
- 7.3.1 Overview
- 7.3.2 Amphotericin B: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Systemic Oral Azoles
- 7.4.1 Overview
- 7.4.2 Systemic Oral Azoles: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Topical
- 7.5.1 Overview
- 7.5.2 Topical: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Antifungal Agents
- 7.6.1 Overview
- 7.6.2 Antifungal Agents: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Systemic Aspergillosis and Systemic Candidasis Market Analysis – by Application
8.1 Chronic
- 8.1.1 Overview
- 8.1.2 Chronic: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Pulmonary Aspergillosis
- 8.2.1 Overview
- 8.2.2 Pulmonary Aspergillosis: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Allergic
- 8.3.1 Overview
- 8.3.2 Allergic: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Bronchopulmonary Aspergillosis
- 8.4.1 Overview
- 8.4.2 Bronchopulmonary Aspergillosis: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Gastrointestinal Candidiasis
- 8.5.1 Overview
- 8.5.2 Gastrointestinal Candidiasis: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.6 Genitourinary Tract Candidiasis
- 8.6.1 Overview
- 8.6.2 Genitourinary Tract Candidiasis: Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Systemic Aspergillosis and Systemic Candidasis Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 UK: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Type
- 9.2.1.1.2 UK: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Application
- 9.2.1.2 Germany:
Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Germany: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Type
- 9.2.1.2.2 Germany: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Application
- 9.2.1.3 France:
Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 France: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Type
- 9.2.1.3.2 France: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Application
- 9.2.1.4 Russia:
Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Russia: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Type
- 9.2.1.4.2 Russia: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Application
- 9.2.1.5 Italy:
Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.5.1 Italy: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Type
- 9.2.1.5.2 Italy: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Application
- 9.2.1.6 Rest of Europe:
Europe Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Type
- 9.2.1.6.2 Rest of Europe: Europe Systemic Aspergillosis and Systemic Candidasis Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Novartis AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sanofi
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Pfizer Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Merck & Co., Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bayer AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Astellas Pharma Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 GlaxoSmithKline plc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Abbott
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Cipla Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Enzon Pharmaceuticals, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Systemic Aspergillosis and Systemic Candidasis Market
